CA Stock MarketDetailed Quotes

RVX Resverlogix Corp

Watchlist
  • 0.035
  • -0.010-22.22%
15min DelayTrading May 1 10:39 ET
9.82MMarket Cap-0.81P/E (TTM)

About Resverlogix Corp Company

Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra terminal) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. Apabetalone is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. This selective inhibition of apabetalone on BD2 produces a specific set of biological effects with potentially important benefits for patients with chronic disease including cardiovascular disease (CVD) and associated comorbidities, and COVID-19.

Company Profile

SymbolRVX
Company NameResverlogix Corp
Founded2000
MarketTSE
Employees18
Fiscal Year Ends12-31
Address4820 Richard Road South West Suite 300
CityCalgary
CountryCAN
Zip CodeT3E 6L1
Phone+1 403 254-9252

Company Executives

  • Name
  • Position
  • Salary
  • Donald J. McCaffrey
  • Chairman of the Board, President, Secretary and Chief Executive Officer
  • --
  • A. Brad Cann, C.A.,C.P.A.
  • Chief Financial Officer
  • --
  • Dr. Ewelina Kulikowski, PhD
  • Senior Vice President, Scientific Development and Chief Scientific Officer
  • --
  • Dr. Michael Sweeney,M.D.
  • Senior Vice President, Clinical Development
  • --
  • Siu Lun To
  • Independent Director
  • --
  • Kenneth J. Zuerblis
  • Independent Director
  • --
  • Kelly McNeill, B.Comm.,C.A.
  • Independent Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More